U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C3H5NO2
Molecular Weight 87.0773
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2,3-EPOXYPROPANAMIDE

SMILES

NC(=O)C1CO1

InChI

InChIKey=FMAZQSYXRGRESX-UHFFFAOYSA-N
InChI=1S/C3H5NO2/c4-3(5)2-1-6-2/h2H,1H2,(H2,4,5)

HIDE SMILES / InChI

Molecular Formula C3H5NO2
Molecular Weight 87.0773
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

PubMed

PubMed

TitleDatePubMed
N-Acetyl-S-(1-carbamoyl-2-hydroxy-ethyl)-L-cysteine (iso-GAMA) a further product of human metabolism of acrylamide: comparison with the simultaneously excreted other mercaptuic acids.
2009-07
DNA adduct formation and induction of micronuclei and mutations in B6C3F1/Tk mice treated neonatally with acrylamide or glycidamide.
2009-05-01
Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide.
2009-04
Toxicokinetics of acrylamide in rats and humans following single oral administration of low doses.
2009-03-01
Acrylamide in children--exposure assessment via urinary acrylamide metabolites as biomarkers.
2009-03
Investigation of the low-dose response in the in vivo induction of micronuclei and adducts by acrylamide.
2009-01
Simultaneous determination of acrylamide, its metabolite glycidamide and antipyrine in human placental perfusion fluid and placental tissue by liquid chromatography-electrospray tandem mass spectrometry.
2008-12-15
Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide.
2008-12
Rapid and sensitive HILIC-ESI-MS/MS quantitation of polar metabolites of acrylamide in human urine using column switching with an online trap column.
2008-11-12
Transplacental transfer of acrylamide and glycidamide are comparable to that of antipyrine in perfused human placenta.
2008-11-10
Low-acrylamide French fries and potato chips.
2008-10
Human CYP2E1 mediates the formation of glycidamide from acrylamide.
2008-10
Carcinogenicity of acrylamide: a computational study.
2008-09-24
Genotoxicity of glycidamide in comparison to 3-N-nitroso-oxazolidin-2-one.
2008-08-13
Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
2008-08-13
Approach for cancer risk estimation of acrylamide in food on the basis of animal cancer tests and in vivo dosimetry.
2008-08-13
Acrylamide carcinogenicity.
2008-08-13
Hemoglobin adducts and mercapturic acid excretion of acrylamide and glycidamide in one study population.
2008-08-13
Development of a stable isotope dilution assay for the quantitation of glycidamide and its application to foods and model systems.
2008-08-13
Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1).
2008-08
Internal doses of acrylamide and glycidamide in mice fed diets with low acrylamide contents.
2008-08
The effects of subchronic acrylamide exposure on gene expression, neurochemistry, hormones, and histopathology in the hypothalamus-pituitary-thyroid axis of male Fischer 344 rats.
2008-07-15
Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study.
2008-05-01
Minireview on the toxicity of dietary acrylamide.
2008-04
Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells.
2008-02
Effects of perinatal exposure to acrylamide and glycidamide on intestinal tumorigenesis in Min/+ mice and their wild-type litter mates.
2008-01-30
Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differences.
2007-12
Urinary metabolites as biomarkers of acrylamide exposure in mice following dietary crisp bread administration or subcutaneous injection.
2007-12
Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans.
2007-11
Expression profile of human cells in culture exposed to glycidamide, a reactive metabolite of the heat-induced food carcinogen acrylamide.
2007-10-30
Analysis of hemoglobin adducts of acrylamide and glycidamide by liquid chromatography-electrospray ionization tandem mass spectrometry, as exposure biomarkers in French population.
2007-10-12
Acrylamide effects on kinesin-related proteins of the mitotic/meiotic spindle.
2007-07-01
Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide.
2007-07
An absorption study of dietary administered acrylamide in swine.
2007-07
Urinary acrylamide metabolites as biomarkers for short-term dietary exposure to acrylamide.
2007-06
Physiologically based pharmacokinetic/pharmacodynamic model for acrylamide and its metabolites in mice, rats, and humans.
2007-03
Urinary excretion of acrylamide and metabolites in Fischer 344 rats and B6C3F(1) mice administered a single dose of acrylamide.
2007-02-28
Cytogenetic damage induced by acrylamide and glycidamide in mammalian cells: correlation with specific glycidamide-DNA adducts.
2007-02
Reaction of glycidamide with 2'-deoxyadenosine and 2'-deoxyguanosine--mechanism for the amide hydrolysis.
2007
Acrylamide exposure via the diet: influence of fasting on urinary mercapturic acid metabolite excretion in humans.
2006-12
Metabolism of acrylamide to glycidamide and their cytotoxicity in isolated rat hepatocytes: protective effects of GSH precursors.
2006-12
Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide.
2006-11-15
Quantitation of mercapturic acids from acrylamide and glycidamide in human urine using a column switching tool with two trap columns and electrospray tandem mass spectrometry.
2006-10-27
Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures.
2006-09-26
Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
2006-09-16
Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers.
2006-09
Genotoxicity of glycidamide in comparison to (+/-)-anti-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide and alpha-acetoxy-N-nitroso-diethanolamine in human blood and in mammalian V79-cells.
2006-04
Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity.
2006-02
Reagent controlled addition of chiral sulfur ylides to chiral aldehydes.
2005-08-26
[Recent trends in evaluating risk associated with acrylamide in foods. --Focus on a new approach (MOE) to risk assessment by JECFA--].
2005
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:24:30 GMT 2025
Edited
by admin
on Mon Mar 31 22:24:30 GMT 2025
Record UNII
6G5ELX5XYN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLYCIDAMIDE
HSDB  
Preferred Name English
2,3-EPOXYPROPANAMIDE
Systematic Name English
GLYCIDIC ACID AMIDE
Systematic Name English
OXIRANE-2-CARBOXAMIDE
Systematic Name English
GLYCIDAMIDE [HSDB]
Common Name English
2-OXIRANECARBOXAMIDE
Systematic Name English
OXIRANECARBOXAMIDE
Systematic Name English
(±)-OXIRANECARBOXAMIDE
Systematic Name English
GLYCAMIDE-
Common Name English
Code System Code Type Description
WIKIPEDIA
Glycidamide
Created by admin on Mon Mar 31 22:24:30 GMT 2025 , Edited by admin on Mon Mar 31 22:24:30 GMT 2025
PRIMARY
CAS
5694-00-8
Created by admin on Mon Mar 31 22:24:30 GMT 2025 , Edited by admin on Mon Mar 31 22:24:30 GMT 2025
PRIMARY
EPA CompTox
DTXSID2031374
Created by admin on Mon Mar 31 22:24:30 GMT 2025 , Edited by admin on Mon Mar 31 22:24:30 GMT 2025
PRIMARY
ECHA (EC/EINECS)
227-163-2
Created by admin on Mon Mar 31 22:24:30 GMT 2025 , Edited by admin on Mon Mar 31 22:24:30 GMT 2025
PRIMARY
PUBCHEM
91550
Created by admin on Mon Mar 31 22:24:30 GMT 2025 , Edited by admin on Mon Mar 31 22:24:30 GMT 2025
PRIMARY
FDA UNII
6G5ELX5XYN
Created by admin on Mon Mar 31 22:24:30 GMT 2025 , Edited by admin on Mon Mar 31 22:24:30 GMT 2025
PRIMARY
HSDB
7804
Created by admin on Mon Mar 31 22:24:30 GMT 2025 , Edited by admin on Mon Mar 31 22:24:30 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE